Free

FDA/FTC Workshop on a Competitive Marketplace for Biosimilars

Event Information

Share this event

Date and Time

Location

Location

FDA White Oak Conference Center

10903 New Hampshire Avenue

Great Room, Building 31, Room 1503 A

Silver Spring, MD 20903

View Map

Event description
The FDA and the FTC are announcing a public workshop on a competitive marketplace for biosimilars.

About this Event

The Food and Drug Administration, in collaboration with the Federal Trade Commission (FTC), is announcing a public workshop on March 9, 2020, "FDA/FTC Workshop on a Competitive Marketplace for Biosimilars." The purpose of the public workshop is to discuss FDA and FTC’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading communications about biosimilars, and deter anticompetitive behaviors in the biologic marketplace.

For more information, please visit the FDA meeting webpage:

https://www.fda.gov/drugs/news-events-human-drugs/public-workshop-fdaftc-workshop-competitive-marketplace-biosimilars-03092020-03092020

Registration

To attend the workshop in-person or by webcast, please register by March 4, 2020. Onsite check-in and registration will begin at 8:00 am EST on March 9, 2020. Registration for online attendance via webcast will remain open throughout the day of the workshop.

Requests for Oral Presentations

There will be time allotted during the workshop for open public comments. To participate in this session, please register by February 24, 2020; however, if time is available, you may sign up as an open public speaker the day of the meeting. Time and space are limited and available on a first-come, first-served basis. Open public speakers may be assigned no more than 5 minutes for their presentation and will deliver oral testimony only (no accompanying slide deck).

Webcast Information

The webcast will begin 30 minutes before the meeting and is accessible through the following link: https://collaboration.fda.gov/fdaftc030920/

To test your webcast connection visit https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

Meeting Agenda

A full agenda will be available approximately 1 week before the meeting at the FDA meeting webpage.

Contact

For additional details, contact the Food and Drug Administration’s Center for Drug and Research Evaluation (CDER), Office of New Drugs, Public Meeting Team at ONDPublicMTGSupport@fda.hhs.gov

Share with friends

Date and Time

Location

FDA White Oak Conference Center

10903 New Hampshire Avenue

Great Room, Building 31, Room 1503 A

Silver Spring, MD 20903

View Map

Save This Event

Event Saved